Getting to the heart of congenital cardiac defects

June 12, 2018, University of North Carolina Health Care
Credit: CC0 Public Domain

Heart defects are the most common type of birth defect, and can be caused by mutations in the gene CHD4. Researchers at the UNC School of Medicine have now revealed key molecular details of how CHD4 mutations lead to heart defects.

The team, in their study published in Proceedings of the National Academy of Sciences this week, found that the CHD4 normally works in developing to repress the production of muscle-filament proteins that are meant to operate in non- types of muscle cell. The failure of this repression leads to the development of abnormal, "hybrid" muscle that can't pump blood as efficiently as normal heart cells.

"For patients with congenital linked to CHD4 mutations, this research helps explain why their hearts don't work as well as normal, and suggests strategies for therapeutic intervention," said study senior author Frank Conlon, Ph.D., a professor in the departments of biology and genetics at UNC and a member of the UNC McAllister Heart Institute.

The research was a collaborative effort involving the Conlon Laboratory, the laboratory of Ian Davis, MD, Ph.D., associate professor in UNC's division of pediatric hematology-oncology, and the laboratory of Paul Wade, Ph.D. at the National Institute of Environmental Health Sciences.

The team, including first author Caralynn M. Wilczewski, a graduate student in the Conlon Laboratory, began by engineering mice whose developing embryos lack CHD4 just in their heart cells. The embryonic mice developed severe cardiac defects midway through gestation and none was born alive. These results confirmed the necessity for CHD4 in heart development.

CHD4, the protein encoded by the CHD4 gene, normally works as part of a multi-protein "machine" that helps regulate gene activity within the nuclei of cells. The researchers therefore conducted a set of experiments to measure and analyze the changes in developing heart-muscle cell gene activity when CHD4 is absent. They found that the CHD4 protein normally binds directly to DNA in a way that represses the activity of genes that encode non-heart muscle proteins. These proteins help make up the springy fibers (myofibrils) that contract and relax when muscles work.

The team determined that when the CHD4 protein is absent, these other, non-cardiac muscle proteins are inappropriately produced in developing heart muscle cells. They become incorporated into the myofibrils in these cells, forming abnormal, hybrid myofibrils that lack the functional properties of the normal heart.

Wilczewski developed an advanced ultrasound technique and used it to record the activity of the tiny hearts developing in mice—organs which in mid-gestation are only about as large as the period at the end of this sentence.

"We observed that the hearts lacking CHD4 and having these abnormal cardiac myofibrils had severely reduced ventricular contractions, indicating a loss of the ability to pump blood normally," Wilczewski said.

"These findings indicate that normal cardiac development in mice depends on the repression of non-cardiac myofiber proteins in heart cells, to allow the formation of normal cardiac myofibers capable of sustaining normal heart contractions," Conlon said.

The findings provide the first clear insight into the mechanism of CHD4-related cardiac defects. They also suggest the possibility that restoring the normal repression of non-cardiac myofiber proteins could prevent heart defects in cases where CHD4 is mutated.

The researchers now plan to investigate the ways in which specific human CHD4 mutations lead to .

In addition, they plan to use the new ultrasound technology developed by Wilczewski in further research. "This technology has broad applications for testing models of congenital heart disease," Conlon said.

Explore further: Researchers discover the molecular mechanisms that produce the heart's contractile structure

More information: Caralynn M. Wilczewski et al, CHD4 and the NuRD complex directly control cardiac sarcomere formation, Proceedings of the National Academy of Sciences (2018). DOI: 10.1073/pnas.1722219115

Related Stories

Researchers discover the molecular mechanisms that produce the heart's contractile structure

May 10, 2016
Researchers at the Centro Nacional de Investigaciones Cardiovasculares Carlos III (CNIC) have discovered an essential mechanism underlying the contractile structures in both the heart and skeletal muscle. When this mechanism ...

Cancer cells shown to co-opt DNA 'repair crew'

May 8, 2017
In experiments with human colon cancer cells and mice, a team led by scientists at the Johns Hopkins Kimmel Cancer Center say they have evidence that cancer arises when a normal part of cells' machinery generally used to ...

Preclinical study shows potential to increase the effectiveness of leukemia treatments

October 13, 2015
Preclinical experiments led by a team of researchers at VCU Massey Cancer Center have shown that blocking the production of a protein known as chromodomain helicase DNA-binding protein 4 (CHD4) may help increase the effectiveness ...

'ROCK' off: Study establishes molecular link between genetic defect and heart malformation

February 6, 2012
UNC researchers have discovered how the genetic defect underlying one of the most common congenital heart diseases keeps the critical organ from developing properly. According to the new research, mutations in a gene called ...

Discovery of a key regulatory gene in cardiac valve formation

May 23, 2017
Researchers from the University of Basel in Switzerland have identified a key regulator gene for the formation of cardiac valves - a process crucial to normal embryonic heart development. These results are published in the ...

Recommended for you

Studies reveal role of red meat in gut bacteria, heart disease development

December 10, 2018
In concurrent studies, Cleveland Clinic researchers have uncovered new mechanisms that demonstrate why and how regularly eating red meat can increase the risk of heart disease, and the role gut bacteria play in that process.

Study points to optimal blood pressure treatment for stroke patients

December 10, 2018
Aggressive treatment of hypertension in stroke patients could do more harm than good in the long term, according to a new study from researchers at the University of Georgia.

Predicting leaky heart valves with 3-D printing

December 10, 2018
More than one in eight people aged 75 and older in the United States develop moderate-to-severe blockage of the aortic valve in their hearts, usually caused by calcified deposits that build up on the valve's leaflets and ...

Team uses gene editing to personalize clinical care for family with cardiomyopathy

December 10, 2018
A little over a year ago, a 65-year-old woman with severe hypertrophic cardiomyopathy—a condition in which the heart's muscle becomes abnormally thick, potentially causing dangerous irregular heartbeats—had her genes ...

Increasing statins dose and patient adherence could save more lives

December 7, 2018
Thousands of heart attacks and deaths from cardiovascular disease could be prevented by patients taking higher doses of statins and taking the drugs as advised by doctors.

Progress made in transplanting pig hearts into baboons

December 6, 2018
A large team of researchers from several institutions in Germany, Sweden, Switzerland and the U.S. has transplanted pig hearts into baboons and kept them alive for an extended period of time. In their paper published in the ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.